U.S. COVID-19 deaths drop to lowest level since March 2020, but young adults are a growing challenge

There was encouraging news about America's COVID-19 pandemic on Monday. Deaths from the new coronavirus have dropped to an average of 292 a day, from more than 3,400 a day in mid-January, according to Johns Hopkins University's data, and about 11,400 new cases are reported each day, down from more than 250,000 a day in early January. COVID-19 vaccines are the main cause of the shrinking pandemic in the U.S., and as of Monday, at least 150 million Americans are fully vaccinated.
Even with the pandemic hitting its deadliest point in January, COVID-19 has dropped below accidents, strokes, Alzheimer's, and chronic lower respiratory diseases as a leading cause of death this year, new Centers for Disease Control and Prevention numbers show. Last year, the CDC says, COVID-19 was the No. 3 killer in the U.S., after heart disease and cancer.
About 45 percent of the U.S. population has been fully vaccinated, more than 53 percent has gotten at least one dose of the vaccines, the CDC says, and Virginia became the 16th state to hit 70 percent of adults at least partially vaccinated, Gov. Ralph Northam (D) announced. But the CDC also found that young adults are declining to get vaccinated in numbers that will make it incredibly hard to reach herd immunity.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
While 80 percent of U.S. adults over 65 had been immunized as of May 22, that number was just 38.3 percent for Americans 18 to 29, a CDC analysis found. The vaccination rate among young adults has dropped sharply, and in a separate CDC study, nearly half of the 2,726 respondents under 40 said they are unsure or have no plans to get vaccinated, "with 18- to 24-year-olds being the least likely to have been vaccinated and most likely to be unsure about getting a shot," The Washington Post reports.
The study, conducted from March to May, also found that people with a college degree who live in higher-income households in metropolitan areas were the most likely to be vaccinated, while Black people under 40 with lower incomes, less education, and no insurance who live outside of metropolitan areas were the least likely to say the will get inoculated.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
5 meritorious cartoons about the war on DEI
Cartoons Artists take on self-evident truths, recent history, and more
By The Week US Published
-
Bucatini alla zozzona recipe
The Week Recommends Classic Roman dish is 'slurpy, fun and absolutely heavenly'
By The Week UK Published
-
The UK 'spy cops' scandal, explained
The Explainer Undercover police targeting activist groups conducted intrusive surveillance, with some even embarking on relationships under assumed identities
By The Week UK Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published